Tovetumab (MEDI-575) is an anti-PDGFRalpha monoclonal antibody that selectively blocks the PDGFRalpha signal transduction. Tovetumab can be used in the research of glioblastoma and non-small cell lung cancer (NSCLC)[1][2].
Molecular Weight:
(145.39 kDa)
Purity:
99.49
CAS Number:
[1243266-04-7]
Target:
PDGFR
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted